Skip to main content
德源药业 logo

德源药业 — Investor Relations & Filings

Ticker · 920735 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 569 across all filing types
Latest filing 2025-09-09 Governance Information
Country CN China
Listing Beijing Stock Exchange 920735

About 德源药业

http://www.pharmdy.com

Deyuan Pharmaceutical specializes in the research, development, production, and commercialization of therapeutic drug preparations. The company focuses on chronic disease management, particularly in the fields of endocrinology and cardiovascular health. Its core product line includes treatments for diabetes, hypertension, and hyperlipidemia, featuring medications such as Metformin Hydrochloride sustained-release tablets, Pioglitazone Hydrochloride, and Valsartan. The organization emphasizes technological innovation and maintains rigorous quality control standards across its manufacturing processes. By leveraging advanced formulation technologies, the company develops high-efficacy pharmaceutical solutions aimed at addressing the long-term needs of patients with metabolic and circulatory disorders.

Recent filings

Filing Released Lang Actions
总经理工作细则
Governance Information Classification · 95% confidence The document is titled '总经理工作细则' (General Manager Work Rules) and details the internal management rules and responsibilities of the company's general manager. It includes sections on qualifications, appointment procedures, powers, meeting systems, reporting, and performance evaluation. The document is a formal announcement of internal governance rules passed by the board of directors, with no financial data, no mention of financial results, no shareholder voting results, and no regulatory filings or certifications. It is not a financial report, earnings release, or regulatory filing. It is a governance-related document describing internal rules and management structure. Therefore, it fits best under Governance Information (CGR). The document length is 4386 characters, which is sufficient for a detailed governance report rather than a brief announcement. Hence, the classification is CGR with high confidence.
2025-09-09 Chinese
年报信息披露重大差错责任追究制度
Governance Information Classification · 95% confidence The document is titled '年报信息披露重大差错责任追究制度' which translates to 'Annual Report Information Disclosure Major Error Accountability System'. It is a detailed internal policy document about the responsibility and accountability related to major errors in annual report disclosures. The document includes definitions, standards for identifying major errors in annual reports, procedures for accountability, and related governance rules. It is not the annual report itself, nor an announcement of a report publication. It is a governance/internal control document related to annual report disclosures. Therefore, it fits best under Governance Information (CGR) which covers internal rules and governance practices related to reporting and disclosures. The document length is 4349 characters, which is substantial and contains detailed policy content, not a brief announcement or certification. Hence, the classification is CGR with high confidence.
2025-09-09 Chinese
利润分配管理制度
Regulatory Filings Classification · 95% confidence The document is titled '利润分配管理制度' which translates to 'Profit Distribution Management System'. It details the company's internal policy on profit distribution, including procedures for board and shareholder meetings, dividend policies, and supervisory mechanisms. It includes specific rules, voting results from a board meeting, and references to company law and regulations. The document is a formal announcement of an internal management system related to profit distribution, not a financial report, earnings release, or regulatory filing. It is not a report publication announcement since it contains substantive policy content rather than just announcing a report. It is not a remuneration report, nor a call transcript or capital update. The document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement of an internal management system and policy, which does not fit into other more specific categories.
2025-09-09 Chinese
会计师事务所选聘制度
Governance Information Classification · 95% confidence The document is titled '会计师事务所选聘制度' which translates to 'Accounting Firm Selection System'. It details the internal procedures, rules, and governance related to the selection, appointment, and supervision of the company's accounting firm. It includes sections on the general principles, quality requirements, selection procedures, reappointment, supervision, and other related governance matters. The document is a policy or governance document rather than a financial report, audit report, or announcement of voting results. It does not contain financial statements, audit opinions, or voting outcomes. It is not a report publication announcement since it is substantive and over 5,000 characters. The content aligns best with Governance Information (CGR) as it details internal rules and governance practices related to auditor selection and oversight.
2025-09-09 Chinese
股东会议事规则
Governance Information Classification · 95% confidence The document is titled '股东会议事规则' which translates to 'Shareholders Meeting Rules' or 'Rules of Procedure for Shareholders Meetings'. It is issued by the company's board and details the procedures, powers, and regulations governing shareholders meetings, including voting rights, meeting convocations, proposal submissions, and other governance-related matters. There is no indication that this is an announcement of a meeting, voting results, or a report of financial results. Instead, it is a governance document outlining internal rules and procedures for shareholder meetings. Therefore, it fits best under the category of Governance Information (CGR). The document length is substantial (15,000 characters), indicating it is a full document, not a brief announcement or notice.
2025-09-09 Chinese
对外担保管理制度
Governance Information Classification · 95% confidence The document is titled '对外担保管理制度' which translates to 'External Guarantee Management System' and is issued by the board of directors of Jiangsu Deyuan Pharmaceutical Co., Ltd. It details internal management rules and procedures regarding external guarantees, including approval processes, risk management, and responsibilities. The document includes references to company laws, securities laws, and listing rules, and it was approved by the board and is pending shareholder approval. It is a detailed internal governance document about company policies rather than a financial report, announcement of voting results, or regulatory filing. It does not contain financial statements or earnings data, nor is it a presentation or announcement of a report. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-09-09 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.